Embolization treatment for chronic subdural hematoma in Canada

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the safety and effectiveness of embolizing the middle meningeal artery as a treatment for chronic subdural hematoma (CSDH). Patients presenting with CSDH to the emergency room or neurosurgical outpatient clinic will be screened for enrollment. Those who consent will undergo the embolization procedure, and their outcomes will be monitored through follow-up CT scans and clinical assessments at 1, 3, and 6 months post-treatment. The study aims to determine if this approach reduces the recurrence rate of CSDH, especially in patients at higher risk of recurrence.

Why it matters

Who can join: the full rules

Inclusion Criteria:

\- All patients with subdural hematoma coming to the emergency room or to neurosurgical outpatient clinic.

Exclusion Criteria:

* If informed consent cannot be obtained from the patient or their substitute decision maker.
* Known allergy to liquid embolic agent

Where it's running

• Health Sciences centre
  Winnipeg MB, Manitoba, Canada Recruiting

Study contacts

• Principal investigator: Jai Shankar, MD — University of Manitoba
• Study coordinator: Jai Shankar, MD
• Email: shivajai1@gmail.com
• Phone: 4313734164

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Non-Thermal Plasma Used During Surgery to Help Prevent Recurrent Chronic Subdural Hematoma

  A randomized trial tests whether applying non-thermal plasma during standard surgery to drain a chronic subdural hematoma can reduce recurrence within 6 months.

  Recruiting National Institute of Nuclear Research - Mexico · Ocoyoacac, State of Mexico · NCT07656818

• MMA Embolization with NeoCast for Subacute and Chronic Subdural Hematoma

  This trial tests whether the NeoCast Embolic System safely and effectively works to treat subacute or chronic subdural hematomas after surgery, compared with the Onyx liquid embolic.

  Recruiting Arsenal Medical, Inc. · New Haven, Connecticut and 1 other locations · NCT07541404

• Histoacryl glue embolization of the middle meningeal artery for chronic subdural hematoma (HARMONY)

  This study tests whether injecting Histoacryl glue into the middle meningeal artery can prevent recurrence or worsening of chronic subdural hematoma in adults.

  Recruiting at 3 sites Aesculap AG · Fukuoka, Kitakyushu-city and 5 other locations · NCT07258069

• Scalp block versus general anesthesia for burr‑hole evacuation of subdural hematoma

  This trial tests whether using a scalp block instead of general anesthesia helps adults (18–75) having burr‑hole evacuation of a subdural hematoma.

  Recruiting Sohag University · Sohag · NCT07143799

• Evaluating outcomes in neurosurgery using standardized measures

  This study is trying to see how different factors affect the results of brain surgeries by collecting information from patients before and after their operations.

  Recruiting at 11 sites Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta · Bergamo, BG and 26 other locations · NCT06724029

• Using tranexamic acid to help people with symptomatic subdural hematoma

  This trial tests whether tranexamic acid can help reduce bleeding and speed recovery in adults 45 and older with symptomatic subdural hematoma.

  Recruiting Phase 3 Unity Health Toronto · Toronto, Ontario · NCT05713630

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.